Amphastar Pharmaceuticals, Inc.

CA · United States · Reporting entity ID 100000000273

Total reported 2019–2025

$24.5M

#283 of 2,960 reporting companies — 0% of all reported industry payments

$107K in general payments across 4,872 records, plus $24.4M in research funding across 155 records.

How it breaks down

General payments $107,034

Research funding $24,363,428

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.